Researchers reveal a connection between cellular metabolism and depression, suicidal ideation

Major depressive disorder affects 16.1 million adults in the United States and costs $210 billion annually. While the primary symptoms of depression are psychological, scientists and doctors have come to understand that depression is a complex disease with physical effects throughout the body.

FDA declines to approve Satsuma’s migraine treatment STS101

Share this article STS101 is designed to be an easy-to-use and portable treatment option for migraine patients. Credit: Photoroyalty / Shutterstock.com. The US Food and

January 19, 2024

Zoll to buy Vyaire’s ventilator business with $37M auction bid

Dive Brief: Zoll said Monday it has agreed to acquire Vyaire Medical’s ventilator business after winning an auction of the assets. Vyaire held a virtual

August 21, 2024

BridgeBio raises up to $1.2B, a month after submitting cardio drug to FDA

BridgeBio has tapped investors for up to $1.25 billion as it prepares to commercialize its heart pill and get some breathing room to continue running

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.